United States· US:47335-722_53dfe063-e9bf-4069-b4cc-5a83a27d18ec
Febuxostat
A febuxostat product containing febuxostat, registered in United States by Sun Pharmaceutical Industries, Inc.. The same ATC class is registered in 19 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Febuxostat is registered in 19 of 19 countries.
Countries holding a registration under ATC M04AA03 (febuxostat), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 11 of them publish a price we can compare per daily dose
Febuxostat · ATC M04AA03
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of febuxostat costs, country by country.
Normalised to the WHO defined daily dose (80 mg), the median price runs from $0.34 in France to $1.89 in Switzerland — a ×5.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Febuxostat · price per daily dose (80 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.89
- IT Italy$0.69
- ES Spain$0.54
- FR France$0.34
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FEBUXOSTAT
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Country
- United States (US)
- ATC code
- M04AA03
- ATC class
- Febuxostat
- Defined daily dose
- 80 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1147335722181000 TABLET, FILM COATED in 1 BOTTLE (47335-722-18)
- ndc11473357228330 TABLET, FILM COATED in 1 BOTTLE (47335-722-83)
- ndc114733572288100 TABLET, FILM COATED in 1 BOTTLE (47335-722-88)
- ndc1147335-722-18
- ndc1147335-722-83
- ndc1147335-722-88
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for febuxostat.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Febuxostat · interactions on record
25 records
- 6 severe
- 19 moderate
Most severe, free to view
- MercaptopurineL01BB02severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Febuxostat in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaADENURICMenarini International Operations Luxembourg S.A., Luxembourg
- SpainADENURIC 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULAMenarini International Operations Luxembourg S.A.
- ItalyADENURICMENARINI INTERNAT. O.L.S.A
- PolandAdenuricMenarini International Operations Luxembourg S.A.
- NetherlandsAdenuric 80 mg, filmomhulde tablettenMenarini International Operations Luxembourg S.A.
- FranceADENURIC 80 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- SwitzerlandAdenuric
- FinlandADENURICAbacus Medicine A/S
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Feburo, Febuxostat +pharma
- Belgium · Feburik, Febuxostat Ab
- Bulgaria · Адара, Адара 80 Mg Филмирани Таблетки
- Cyprus · Febuxostat Genepharm, Urichofeb
- Czechia · Febuxostat Sandoz
- Germany · Febuxodor, Febuxostat 1 A Pharma
- Denmark · Febuxostat Accord, Febuxostat Teva
- Estonia · Druniler, Febuxostat Alembic
- Spain · Febuxostat Aurovitas, Febuxostat Cinfa
- Finland · Febuxostat Accord
- France · Febuxostat Accord, Febuxostat Almus
- United Kingdom (Northern Ireland) · Elstabya, Febuxostat
- Greece · Buxodem, Febuxostat Genepharm
- Croatia · Abuxar, Febuksostat
- Hungary · Denofix, Doluric
- Ireland · Febuxostat Clonmel, Febuxostat Rowa
- Iceland · Adenuric, Febuxostat Krka
- Italy · Alphabux, Arbux
- Liechtenstein · Adenuric, Febuxostat Viatris
- Lithuania · Druniler, Febuxostat Teva
- Luxembourg · Feburik, Febuxostat
- Latvia · Denofix, Druniler
- Malta · Febuxostat Pharos
- Netherlands · Feburik, Febuxostat Laboratorios Liconsa
- Norway · Adenuric, Febuxostat Krka
- Poland · Denofix, Febuxostat Aurovitas
- Portugal · Bluesar, Febuxostate Aristo
- Sweden · Feburo
- Slovenia · Abuxar
- Slovakia · Febuxostat Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/478926b6-7baf-4415-97d9-6d8fe82feed6 GET /v1/drugs/478926b6-7baf-4415-97d9-6d8fe82feed6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "80",
"substance": "FEBUXOSTAT",
"productndc": "47335-722",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA205467",
"marketing_category": "ANDA"
}See everything about febuxostat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.